A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

I was told that my pain would last for the rest of my life,” Berenice Holt, 44, says. “That there were only ways to manage it ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

Even a myriad of medications — pain relievers and anti-nausea and migraine drugs — haven’t helped the high school senior, who ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Licensed in the UK to treat depression since 2015, rTMS works for both depression and chronic pain by activating the parts of the brain that become less active because of long-term mental illness ...